Peter Sorger
Directeur/Membre du Conseil chez Glencoe Software, Inc.
Profil
Peter Sorger is currently a Director at Applied BioMath LLC, Glencoe Software, Inc., and a Professor-Systems Pharmacology at Harvard Medical School.
He previously worked as a Director at Merrimack Pharmaceuticals, Inc. and RareCyte, Inc. Sorger holds a doctorate degree from Trinity College, Cambridge and an undergraduate degree from Harvard College.
Postes actifs de Peter Sorger
| Sociétés | Poste | Début |
|---|---|---|
Glencoe Software, Inc.
 Glencoe Software, Inc. Miscellaneous Commercial ServicesCommercial Services Glencoe Software, Inc. provides scientific image data solutions. It products include OMERO Plus, Bio-Formats, PathViewer, DataViewer and Data InPress. The firm offers customization, support and data publishing services. The company was founded by Jason Swedlow in 2005 and is headquartered in Seattle, WA. | Directeur/Membre du Conseil | - |
| Harvard Medical School | Corporate Officer/Principal | - |
Applied BioMath LLC
 Applied BioMath LLC Packaged SoftwareTechnology Services Applied BioMath LLC operates as a biotechnology company. The firm uses mathematical modeling and simulation to provide quantitative and predictive guidance to biotechnology and pharmaceutical companies to help accelerate and de-risk drug research and development. It specializes in mechanistic PK/PD, quantitative decision making, risk assessments, predict optimal drug properties for lead gen or clinical candidate selection, phase 1 and phase 2 support and analysis, technical due diligence. The company was founded by John M. Burke, Joshua Apgar and Andrew Sutherland in 2013 and is headquartered in Concord, MA. | Directeur/Membre du Conseil | - |
Anciens postes connus de Peter Sorger
| Sociétés | Poste | Fin |
|---|---|---|
| MERRIMACK PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | - |
RareCyte, Inc.
 RareCyte, Inc. Medical SpecialtiesHealth Technology RareCyte Inc. develops life science research and diagnostic that focuses on characterizing and isolating rare cells in the blood. It engages in bringing its technology to the life sciences research, drug development and diagnostic markets providing new tools to answer difficult questions related to cancer and cardiovascular disease. It's ground-breaking sccuCyte system is an open platform for the unbiased discovery and isolation of circulating tumor cells and circulating endothelial cells from whole blood. The company was founded by Ronald Seubert in 2009 and is headquartered in Seattle, WA. | Directeur/Membre du Conseil | - |
Formation de Peter Sorger
| Harvard College | Undergraduate Degree |
| Trinity College, Cambridge | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MERRIMACK PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
RareCyte, Inc.
RareCyte, Inc. Medical SpecialtiesHealth Technology RareCyte Inc. develops life science research and diagnostic that focuses on characterizing and isolating rare cells in the blood. It engages in bringing its technology to the life sciences research, drug development and diagnostic markets providing new tools to answer difficult questions related to cancer and cardiovascular disease. It's ground-breaking sccuCyte system is an open platform for the unbiased discovery and isolation of circulating tumor cells and circulating endothelial cells from whole blood. The company was founded by Ronald Seubert in 2009 and is headquartered in Seattle, WA. | Health Technology |
Glencoe Software, Inc.
Glencoe Software, Inc. Miscellaneous Commercial ServicesCommercial Services Glencoe Software, Inc. provides scientific image data solutions. It products include OMERO Plus, Bio-Formats, PathViewer, DataViewer and Data InPress. The firm offers customization, support and data publishing services. The company was founded by Jason Swedlow in 2005 and is headquartered in Seattle, WA. | Commercial Services |
Applied BioMath LLC
Applied BioMath LLC Packaged SoftwareTechnology Services Applied BioMath LLC operates as a biotechnology company. The firm uses mathematical modeling and simulation to provide quantitative and predictive guidance to biotechnology and pharmaceutical companies to help accelerate and de-risk drug research and development. It specializes in mechanistic PK/PD, quantitative decision making, risk assessments, predict optimal drug properties for lead gen or clinical candidate selection, phase 1 and phase 2 support and analysis, technical due diligence. The company was founded by John M. Burke, Joshua Apgar and Andrew Sutherland in 2013 and is headquartered in Concord, MA. | Technology Services |